American Society of Hematology

Newsroom

ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.

Need to speak with an expert? Complete our Request An Expert form.

To be added to ASH's press release distribution list, contact Stephen Fitzmaurice at sfitzmaurice@hematology.org.

Latest Press Releases

  • People Willing to Trade Treatment Efficacy for Reduced Side Effects in Cancer Therapies Nov 21, 2017

    When choosing their preferred treatment, people with chronic lymphocytic leukemia place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a study published online in Blood Advances. The study also suggests that factoring out-of-pocket costs into this decision-making process may significantly influence a patient’s choice of treatment.

  • American Society of Hematology Announces Top Trainee Abstracts of 2017 ASH Annual Meeting Nov 09, 2017

    The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 59th ASH Annual Meeting December 9-12 in Atlanta.

  • New Leadership Elected to American Society of Hematology Nov 01, 2017

    The American Society of Hematology, the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the election of three new members to its Executive Committee for terms beginning after the 2017 ASH Annual Meeting December 9-12 in Atlanta.

View all